Return to content in this issue
Efficacy of Benralizumab and Clinical Course of IgG4 in Eosinophilic Granulomatosis With Polyangiitis
Miyata Y, Inoue H, Homma T, Tanaka A, Sagara H
Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan
J Investig Allergol Clin Immunol 2021; Vol 31(4)
: 346-348
doi: 10.18176/jiaci.0648
Key words: Eosinophilic granulomatosis with polyangiitis (EGPA), Benralizumab, Anti-IL-5 receptor antibody, IgG4, MPO-ANCA